Abbott Laboratories (ABT) Total Liabilities (2009 - 2026)

Abbott Laboratories has disclosed Total Liabilities across 18 years of filings, most recently posting $57.5 billion for Q2 2026.

• In Q2 2026, Total Liabilities rose 73.21% year-over-year to $57.5 billion; the TTM figure through Jun 2026 stood at $57.5 billion (up 73.21% YoY), while the FY2025 annual figure was $33.9 billion, up 1.28% from the prior year.
• Total Liabilities came in at $57.5 billion for Q2 2026 at Abbott Laboratories, roughly flat from $57.7 billion in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $57.7 billion in Q1 2026 to a low of $32.4 billion in Q1 2025.
• Average Total Liabilities over 5 years is $37.4 billion, with a median of $34.4 billion recorded in 2023.
• Year-over-year, Total Liabilities decreased 8.58% in 2024 and jumped 78.26% in 2026.
• Over 5 years, Total Liabilities stood at $37.5 billion in 2022, then declined by 8.38% to $34.4 billion in 2023, then declined by 2.54% to $33.5 billion in 2024, then grew by 1.28% to $33.9 billion in 2025, then soared by 69.27% to $57.5 billion in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $57.5 billion in Q2 2026, $57.7 billion in Q1 2026, and $33.9 billion in Q4 2025.